{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:52Z","timestamp":1760057272627,"version":"build-2065373602"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Toxicology Foundation","award":["Medical Toxicology Foundation"],"award-info":[{"award-number":["Medical Toxicology Foundation"]}]},{"name":"John A. Marx, MD Scholarship Fund","award":["John A. Marx, MD Scholarship Fund"],"award-info":[{"award-number":["John A. Marx, MD Scholarship Fund"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13181-025-01089-2","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:17:05Z","timestamp":1754324225000},"page":"386-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Treating Nifedipine-Induced Shock with Hydroxocobalamin in a Swine Model"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4885-3083","authenticated-orcid":false,"given":"Christine","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gellar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Rozario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charity G.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William P.","family":"Kerns II","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"12","key":"1089_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15563650.2018.1533727","volume":"56","author":"D Gummin","year":"2018","unstructured":"Gummin D, Mowry J, Spyker D, et al. 2017 annual report of the america\u2019s poison centers\u2019 National poison data system (NPDS): 35th annual report. Clin Toxicol (Phila). 2018;56(12):1\u2013203.","journal-title":"Clin Toxicol (Phila)"},{"key":"1089_CR2","doi-asserted-by":"crossref","unstructured":"Gummin D, Mowry J, Spyker D et al. 2018 annual report of the America\u2019s Poison Centers\u2019 National Poison Data System (NPDS): 36th annual report. Clin Toxicol (Phila). 2019;57(12):1220\u20131413.","DOI":"10.1080\/15563650.2019.1677022"},{"issue":"12","key":"1089_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1080\/15563650.2020.1834219","volume":"58","author":"D Gummin","year":"2020","unstructured":"Gummin D, Mowry J, Beuhler M, et al. 2019 annual report of the america\u2019s poison centers\u2019 National poison data system (NPDS): 37th annual report. Clin Toxicol (Phila). 2020;58(12):1360\u2013541.","journal-title":"Clin Toxicol (Phila)"},{"issue":"12","key":"1089_CR4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/15563650.2021.1989785","volume":"59","author":"D Gummin","year":"2021","unstructured":"Gummin D, Mowry J, Beuhler M, et al. 2020 annual report of the america\u2019s poison centers\u2019 National poison data system (NPDS): 38th annual report. Clin Toxicol (Phila). 2021;59(12):1282\u2013501.","journal-title":"Clin Toxicol (Phila)"},{"key":"1089_CR5","doi-asserted-by":"crossref","unstructured":"Gummin D, Mowry J, Beuhler M et al. 2021 Annual report of the National Poison Data System (NPDS) from America\u2019s Poison Centers: 39th annual report. Clin Toxicol (Phila). 2022;60(12):1381\u20131643.","DOI":"10.1080\/15563650.2022.2132768"},{"issue":"10","key":"1089_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/15563650.2023.2268981","volume":"61","author":"D Gummin","year":"2023","unstructured":"Gummin D, Mowry J, Beuhler M, et al. 2022 annual report of the National poison data system (NPDS) from america\u2019s poison centers: 40th annual report. Clin Toxicol (Phila). 2023;61(10):717\u2013939.","journal-title":"Clin Toxicol (Phila)"},{"key":"1089_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/15563650701285412","volume":"45","author":"JS Holger","year":"2007","unstructured":"Holger JS, Engebretsen KM, Fritzlar S, et al. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol (Phila). 2007;45:396\u2013401.","journal-title":"Clin Toxicol (Phila)"},{"issue":"7","key":"1089_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/15563650.2011.593522","volume":"49","author":"JS Holger","year":"2011","unstructured":"Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM. High dose insulin in toxin-induced cardiogenic shock - a consecutive case series. Clin Toxicol (Phila). 2011;49(7):653\u20138.","journal-title":"Clin Toxicol (Phila)"},{"issue":"8","key":"1089_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3109\/15563650.2010.521753","volume":"48","author":"KM Engebretsen","year":"2010","unstructured":"Engebretsen KM, Morgan M, Stellpflug S, Cole J, Anderson C. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol (Phila). 2010;48(8):806\u201312.","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"1089_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/15563650.2011.582471","volume":"49","author":"KM Engebretsen","year":"2011","unstructured":"Engebretsen KM, Kazmazarek K, Morgan JL, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol (Phila). 2011;49(4):277\u201383.","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"1089_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF03161225","volume":"5","author":"C Page","year":"2009","unstructured":"Page C, Hacket L, Isbister G. The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report. J Med Toxicol. 2009;5(3):139\u201342.","journal-title":"J Med Toxicol"},{"issue":"3","key":"1089_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00003495-199958030-00002","volume":"58","author":"S Dhein","year":"1999","unstructured":"Dhein S, Salameth A, Berkels R, Klaus W. Dual mode of action of dihydropyridine calcium antagonists: a role for nitric oxide. Drugs. 1999;58(3):397\u2013404.","journal-title":"Drugs"},{"key":"1089_CR13","first-page":"75","volume":"6","author":"R Berkels","year":"1996","unstructured":"Berkels R, Bertsch A, Breinbach T, Klaus WRR. The calcium-antagonist Nifedipine stimulates endothelial NO release in therapeutical concentrations. Pharm Pharmacol Lett. 1996;6:75\u20138.","journal-title":"Pharm Pharmacol Lett"},{"key":"1089_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S1081-1206(10)60545-5","volume":"99","author":"P Evora","year":"2007","unstructured":"Evora P, Simon M. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue. Ann Allergy Asthma Immunol. 2007;99:306\u201313.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"1089_CR15","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1172\/JCI25426","volume":"116","author":"A Cauwels","year":"2006","unstructured":"Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P. Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest. 2006;116(8):2244\u201351.","journal-title":"J Clin Invest"},{"issue":"1","key":"1089_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0022-3565(25)32778-3","volume":"219","author":"CA Gruetter","year":"1981","unstructured":"Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between Cyclic Guanosine 3\u2019:5\u2019 monophosphate formation and relaxation of coronary artery smooth muscles by Glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharm Exp Thera. 1981;219(1):181\u20136.","journal-title":"J Pharm Exp Thera"},{"key":"1089_CR17","first-page":"211","volume":"5","author":"CA Gruetter","year":"1979","unstructured":"Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, Nitroprusside and a carcinogenic nitrosoamine. J Cycl Nuleotide Res. 1979;5:211\u201344.","journal-title":"J Cycl Nuleotide Res"},{"issue":"6","key":"1089_CR18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00003246-199606000-00033","volume":"24","author":"I Tsuneyoshi","year":"1996","unstructured":"Tsuneyoshi I, Kanmura Y, Yoshimura N. Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit Care Med. 1996;24(6):1083\u20136.","journal-title":"Crit Care Med"},{"key":"1089_CR19","first-page":"145","volume":"9","author":"F Murad","year":"1978","unstructured":"Murad F, Mittal C, Arnold W, Katsuki S, Kumura H. Guanylate cyclase activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and Inhibition by hemoglobin and myoglobin. Adv Cycl Nucloetide Protein Phosphorylation Res. 1978;9:145\u201358.","journal-title":"Adv Cycl Nucloetide Protein Phosphorylation Res"},{"issue":"12","key":"1089_CR20","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.freeradbiomed.2009.03.017","volume":"46","author":"JB Weinberg","year":"2009","unstructured":"Weinberg JB, Chen Y, Jiang N, Beasley BE, Salerno JC, Chosh DK. Inhibition of nitric oxide synthase by cobalamins and cobinamides. Free Radic Biol Med. 2009;46(12):1626\u201332.","journal-title":"Free Radic Biol Med"},{"key":"1089_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0022-3565(24)37434-8","volume":"285","author":"H Kruszyna","year":"1998","unstructured":"Kruszyna H, Magyar JS, Rochelle LG, Russell MA, Smith RP, Wilcox DE. Spectroscopic studies of nitric oxide interactions with cobalamins: reaction of NO with superoxocobalamin(III) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther. 1998;285:665\u201371.","journal-title":"J Pharmacol Exp Ther"},{"key":"1089_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/15563650600811805","volume":"44","author":"K Gerth","year":"2006","unstructured":"Gerth K, Ehring T, Braendle M, Schelling P. Nitric oxide scavenging by hydroxocobalamin May account for its hemodynamic profile. Clin Toxicol (Phila). 2006;44:29\u201336.","journal-title":"Clin Toxicol (Phila)"},{"key":"1089_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0022-3565(25)12075-2","volume":"275","author":"LG Rochelle","year":"1995","unstructured":"Rochelle LG, Morana SJ, Kruszyna H, Russell MA, Wilcox DE, Smith RP. Interactions between hydroxocobalamin and nitric oxide: evidence for a redox reactions between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther. 1995;275:48\u201352.","journal-title":"J Pharmacol Exp Ther"},{"key":"1089_CR24","unstructured":"FDA. Cyanokit [package insert]. Merck Sante s.a.s., revised 12\/2018. Accessed 3\/5\/2025. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/022041s019, 020lbl.pdf"},{"issue":"S1","key":"1089_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/15563650600811755","volume":"44","author":"W Uhl","year":"2006","unstructured":"Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila). 2006;44(S1):17\u201328.","journal-title":"Clin Toxicol (Phila)"},{"issue":"6","key":"1089_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/15563650701829763","volume":"46","author":"W Uhl","year":"2008","unstructured":"Uhl W, Nolting A, Gallemann D, Hecht S, Kovar A. Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers. Clin Toxicol (Phila). 2008;46(6):551\u201377.","journal-title":"Clin Toxicol (Phila)"},{"key":"1089_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/15563659309000395","volume":"31","author":"JC Forsyth","year":"1993","unstructured":"Forsyth JC, Mueller PD, Becker CE, et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol. 1993;31:277\u201394.","journal-title":"J Toxicol Clin Toxicol"},{"key":"1089_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3109\/15563650.2012.742197","volume":"50","author":"JP Thomson","year":"2012","unstructured":"Thomson JP, Marrs TC. Hydroxocobalamin in cyanide poisoning. Clin Toxicol (Phila). 2012;50:875\u201385.","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"1089_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.jvca.2016.08.019","volume":"31","author":"ML Burnes","year":"2017","unstructured":"Burnes ML, Boettcher BT, Woehlck HJ, Zundel MT, Iqbal Z, Pagel PS. Hydroxocobalamin as a rescue treatment for refractory vasoplegic syndrome after prolonged cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2017;31(3):1012\u20134.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"1089_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12630-017-1029-3","volume":"65","author":"PR Shah","year":"2018","unstructured":"Shah PR, Reynolds PS, Pal N, Tang D, McCarthy H, Spiess BD. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series. Can J Anaesth. 2018;65(5):560\u20138.","journal-title":"Can J Anaesth"},{"issue":"5","key":"1089_CR31","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","volume":"97","author":"JD Rodrique","year":"2014","unstructured":"Rodrique JD, VanDyck K, Holman B, Tang D, Chui B, Spiess BD. The use of high-dose hydroxocobalamin for vasoplegic syndrome. Ann Thorac Surg. 2014;97(5):1785\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"1089_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.annemergmed.2014.02.009","volume":"64","author":"VS Bebarta","year":"2014","unstructured":"Bebarta VS, Tanen DA, Boudreau S, et al. Intravenous Cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model. Ann Emerg Med. 2014;64(6):612\u20139.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"1089_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.annemergmed.2009.09.020","volume":"55","author":"VS Bebarta","year":"2010","unstructured":"Bebarta VS, Tanan D, Lairet J, Dixon P, Valtier S, Bush A. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med. 2010;55(4):345\u201351.","journal-title":"Ann Emerg Med"},{"issue":"6","key":"1089_CR34","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.annemergmed.2012.01.022","volume":"59","author":"VS Bebarta","year":"2012","unstructured":"Bebarta VS, Pitotti RL, Dixon P, Lairet JR, Bush A, Tanen D. Hydroxocobalamin versus sodium thiosulfate for the treatment of acute cyanide toxicity in a swine (Sus Scrofa) model. Ann Emerg Med. 2012;59(6):532\u20139.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"1089_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/1440-1681.13060","volume":"46","author":"VS Bebarta","year":"2019","unstructured":"Bebarta VS, Garrett N, Maddry JK, et al. A prospective, randomized trial of intravenous hydroxocobalamin versus noradrenaline or saline for treatment of lipopolysaccharide-induced hypotension in a swine model. Clin Exp Pharmacol Physiol. 2019;46(3):216\u201325.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"1089_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5055\/ajdm.2015.0203","volume":"10","author":"VS Bebarta","year":"2015","unstructured":"Bebarta VS, Garrett N, Boudreau S, Castaneda M. Intraosseous hydroxocobalamin versus intravenous hydroxocobalamin compared to intraosseous whole blood or no treatment for hemorrhagic shock in a swine model. Am J Disaster Med. 2015;10(3):205\u201315.","journal-title":"Am J Disaster Med"},{"issue":"3","key":"1089_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/acem.12605","volume":"22","author":"VS Bebarta","year":"2015","unstructured":"Bebarta VS, Garrett N, Boudreau S, Castaneda M. A prospective, randomized trial of intravenous hydroxocobalamin versus whole blood transfusion compared to no treatmet for class III hemorrhagic shock resuscitation in a prehospital swine model. Acad Emerg Med. 2015;22(3):321\u201330.","journal-title":"Acad Emerg Med"},{"issue":"2S Suppl 1","key":"1089_CR38","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1097\/TA.0000000000004049","volume":"95","author":"RM Paredes","year":"2023","unstructured":"Paredes RM, Castaneda M, Mireles AA, Rodriguez D, Maddry J. Comparison of hydroxocobalamin with other resuscitative fluids in volume-controlled and uncontrolled hemorrhage models in swine (Sus scrofa). J Trauma Acute Care Surg. 2023;95(2S Suppl 1):S120\u20138.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"1089_CR39","first-page":"e13388","volume":"13","author":"HJ Gerdes","year":"2021","unstructured":"Gerdes HJ, Seelhammer TG, Nei S, Diaz Soto J, Nabzdyk CG. Extended duration infusion of hydroxocobalamin for vasoplegic rescue in septic shock. Cureus. 2021;13(2):e13388.","journal-title":"Cureus"},{"issue":"2","key":"1089_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.hrtlng.2020.11.003","volume":"50","author":"TG Seelhammer","year":"2021","unstructured":"Seelhammer TG, Plack D, Nei S, Wittwer E, Nelson J, Nabzdyk CGS. Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery. Heart Lung. 2021;50(2):173\u20136.","journal-title":"Heart Lung"},{"issue":"6","key":"1089_CR41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.annemergmed.2014.02.009","volume":"64","author":"VS Bebarta","year":"2014","unstructured":"Bebarta VS, Tanen DA, Boudreau S, et al. Intravenous Cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in swine (Sus scrofa) model. Ann Emerg Med. 2014;64(6):612\u20136.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"1089_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.annemergmed.2012.02.002","volume":"60","author":"VS Bebarta","year":"2012","unstructured":"Bebarta VS, Pitotti R, Dixon P, et al. Hydroxocobalamin and epinephrine both improve survival Ina swine model of cyanide-induced cardiac arrest. Ann Emerge Med. 2012;60(4):415\u201322.","journal-title":"Ann Emerge Med"},{"issue":"4","key":"1089_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/CCM.0000000000005436","volume":"50","author":"M Di Nardo","year":"2022","unstructured":"Di Nardo M, Fegatelli D, Marano M, Danoff J, Kim H. Use of extracoroporeal membrane oxygenation in acutely poisoned pediatric patients in united states: a retropsective analysis of the extracorporeal life support registry from 2003\u20132019. Crit Care Med. 2022;50(4):655\u201364.","journal-title":"Crit Care Med"},{"issue":"4","key":"1089_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s13181-016-0572-6","volume":"12","author":"CM Murphy","year":"2016","unstructured":"Murphy CM, Williams C, Quinn M, Nicholson B, Shoe T, Beuhler MC, Kerns WP. Pilot trial of intravenous lipid emulsion treatment for severe nifedipine-induced shock. J Med Toxicol. 2016;12(4):380\u20135.","journal-title":"J Med Toxicol"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-025-01089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-025-01089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-025-01089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:03:23Z","timestamp":1760025803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-025-01089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1007\/s13181-025-01089-2","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"type":"print","value":"1556-9039"},{"type":"electronic","value":"1937-6995"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was presented at the American College of Medical Toxicology Annual Scientific Meeting in Huntington Beach, California, 2016.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous Presentation"}},{"value":"None to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}